Stephen Luen
Dr Stephen Luen is an early career Medical Oncologist and translational researcher at the Peter MacCallum Cancer Centre specialising in breast cancer, sarcoma, early drug development, and precision oncology. In 2021, he completed a PhD supervised by Professor Sherene Loi investigating genomic and immune biomarkers in early-stage breast cancers, and continues to work closely with the laboratory. His current research interests include the study of genomic and immune biomarkers in high-risk and treatment-refractory breast cancers, the development of novel clinical trial approaches for high-risk breast cancers, and the early phase development of new therapeutic compounds.
Abstracts this author is presenting:
